Population pharmacokinetics of pegaptanib sodium (Macugen(®)) in patients with diabetic macular edema.

Objective: Population pharmacokinetic modeling of pegaptanib was undertaken to determine influence of renal function on apparent clearance.

Methods: In a randomized, double-masked multicenter trial, intravitreal pegaptanib (0.3, 1.